Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Increasing TSPO in the brain may help improve memory problems.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Prostaglandin helps regenerate hair follicles after radiation damage.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Gefitinib can cause scalp skin issues and permanent hair loss.

The nano-carrier makes etoposide safer and more effective against lung cancer.

A cream with a specific hormone blocker increases hair growth in mice.

New compounds were found to help increase hair growth and decrease hair loss.